Swissmedic Approves PEDMARQSI® for the Prevention of Cisplatin-Induced Hearing Loss in Children
AMSTERDAM, THE NETHERLANDS – Norgine B.V., a leading European specialty pharmaceutical company, has announced a significant breakthrough for pediatric oncology patients in Switzerland. Swissmedic, the Swiss Agency for Therapeutic Products,…
